Bioventus Inc.

Bioventus Inc. is a medical device company focused on relieving pain and addressing musculoskeletal therapies. Its product portfolio includes pain treatments such as intra-articular and hyaluronic acid injections like Durolane, GELSYN-3, and SUPARTZ for knee osteoarthritis. It also offers peripheral nerve stimulation products including Stimrouter for chronic peripheral pain and TalisMann for targeted peripheral nerve stimulation. Additionally, Bioventus provides surgical solutions like the BoneScalpel ultrasonic system for precise bone cutting, the SonaStar system for soft tissue ablation, and the neXus ultrasonic surgical system. The company also supplies bone graft substitutes such as Osteoamp, Signafuse, Purebone, and Reficio for orthopedic and neurosurgical procedures.

Bioventus Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol BVS. Its shares are traded in United States Dollars (USD), reflecting its primary listing in the United States. The company is headquartered in the United States and operates within the US financial market, making USD the relevant currency for its stock transactions and financial reporting.

Bioventus Inc. operates in the Healthcare sector, specifically within the Medical Devices industry. As a medical device company, it develops and markets products that address musculoskeletal conditions and pain management. Its offerings range from non-surgical treatments like hyaluronic acid injections to advanced surgical tools such as ultrasonic bone scalpels and nerve stimulation devices. This industry classification reflects the company's focus on therapeutic and surgical solutions for orthopedic and neurological applications.

Bioventus Inc. serves the United States and global markets. The company's description indicates that it operates in the United States and internationally, with a product portfolio that includes pain treatments, surgical systems, and bone graft substitutes distributed worldwide. While its headquarters and primary listing are in the US, its products are used in various countries, addressing musculoskeletal therapies and pain relief on a global scale.

Bioventus Inc.'s portfolio includes several notable products across different categories. For pain management, it offers Durolane, GELSYN-3, and SUPARTZ (hyaluronic acid injections for knee osteoarthritis) and the Stimrouter and TalisMann peripheral nerve stimulation systems for chronic pain. In surgical solutions, it provides the BoneScalpel and BoneScalpel Access for precise bone cutting, the SonaStar system for soft tissue ablation, the neXus ultrasonic surgical system, and the SonicOne for ultrasonic cleansing and debridement. For bone grafting, it offers Osteoamp (allograft-derived), Signafuse, Purebone (osteoconductive scaffold), and Reficio demineralized bone matrix. Additionally, the XCELL PRP System processes whole blood to produce high-yield platelet-rich plasma.